Astrazeneca vaccine : Live Updates Every Minute from 25K+ News Agencies Across the Globe
Pause on COVID-19 vaccine lifted for eligible under 50s
Health
by Evin Priest
Victoria's pause on the AstraZeneca vaccine for eligible people aged under 50 will be lifted from Wednesday.
The halt on administering the vaccine came after advice from the Australian Technical Advisory Group on Immunisation (ATAGI), following blood clotting concerns linked to the AstraZeneca vaccine.
On Sunday, Victorian Health Minister Martin Foley revealed shoring up indemnity for GPs who give the vaccine was among several factors that allowed the government to remove the pause on the AstraZeneca for eligible people under the age of 50.
"By Wednesday, our health professionals will have everything they need to administer AstraZeneca to eligible Victorians of all ages and they will continue to do so to the highest standards of safety and quality," Mr Foley said.
Health
by Evin Priest
Victoria's pause on the AstraZeneca vaccine for eligible people aged under 50 will be lifted from Wednesday.
The halt on administering the vaccine came after advice from the Australian Technical Advisory Group on Immunisation (ATAGI), following blood clotting concerns linked to the AstraZeneca vaccine.
On Sunday, Victorian Health Minister Martin Foley revealed shoring up indemnity for GPs who give the vaccine was among several factors that allowed the government to remove the pause on the AstraZeneca for eligible people under the age of 50.
"By Wednesday, our health professionals will have everything they need to administer AstraZeneca to eligible Victorians of all ages and they will continue to do so to the highest standards of safety and quality," Mr Foley said.
New plan for Aussie-made vaccine
Health
by Finn McHugh
18th Apr 2021 5:50 PM
Australia is interested in producing a cutting-edge form of COVID-19 vaccine onshore, but the Health Minister warns it could take the "best part of a year" for manufacturing to begin.
Greg Hunt says the federal government has a "very high interest" in producing mRNA vaccines, potentially including the Pfizer and Moderna jabs, in Australia as it looks to rescue its error-ridden rollout.
It had planned for the AstraZeneca vaccine to make up the bulk of its rollout, with drug manufacturer CSL to produce 50 million doses in Melbourne.
But that plan was thrown into disarray earlier this month when authorities warned against its use in people aged under 50 when possible, making the Pfizer vaccine Australia's preferred jab for 11.2 million recipients.
Health
by Finn McHugh
18th Apr 2021 5:50 PM
Australia is interested in producing a cutting-edge form of COVID-19 vaccine onshore, but the Health Minister warns it could take the "best part of a year" for manufacturing to begin.
Greg Hunt says the federal government has a "very high interest" in producing mRNA vaccines, potentially including the Pfizer and Moderna jabs, in Australia as it looks to rescue its error-ridden rollout.
It had planned for the AstraZeneca vaccine to make up the bulk of its rollout, with drug manufacturer CSL to produce 50 million doses in Melbourne.
But that plan was thrown into disarray earlier this month when authorities warned against its use in people aged under 50 when possible, making the Pfizer vaccine Australia's preferred jab for 11.2 million recipients.
How the tiny kingdom of Bhutan out-vaccinated most of the world
How the tiny kingdom of Bhutan out-vaccinated most of the world
SECTIONS
How the tiny kingdom of Bhutan out-vaccinated most of the worldBy Chencho Dema and Mike Ives, New York Times
Last Updated: Apr 18, 2021, 11:41 PM IST
Share
Synopsis
As of Saturday, Bhutan, a Buddhist kingdom that has emphasized its citizens’ well-being over national prosperity, had administered a first vaccine dose to more than 478,000 people, more than 60% of its population. The Health Ministry said this month that more than 93% of eligible adults had received their first shots.
AFP
Bhutan's vaccination rate was ahead of those of the United Kingdom and the United States, more than seven times that of neighboring India and nearly six times the global average.
How the tiny kingdom of Bhutan out-vaccinated most of the world
SECTIONS
How the tiny kingdom of Bhutan out-vaccinated most of the worldBy Chencho Dema and Mike Ives, New York Times
Last Updated: Apr 18, 2021, 11:41 PM IST
Share
Synopsis
As of Saturday, Bhutan, a Buddhist kingdom that has emphasized its citizens’ well-being over national prosperity, had administered a first vaccine dose to more than 478,000 people, more than 60% of its population. The Health Ministry said this month that more than 93% of eligible adults had received their first shots.
AFP
Bhutan's vaccination rate was ahead of those of the United Kingdom and the United States, more than seven times that of neighboring India and nearly six times the global average.
Children wrongly given AstraZeneca vaccine in Australia
The Therapeutic Goods Administration (TGA) has confirmed the death of a 48-year-old NSW woman was "likely" linked to the AstraZeneca COVID vaccine.
Genene Norris died four days after receiving the vaccine on April 8, after having developed rare blood clots.
After meeting last night, the TGA Vaccine Safety Investigation Group released its report where it declared that a "causative link" to the vaccination "should be assumed at this time".
CHILDREN GIVEN JAB IN ERROR
Teens as young as 14 have been mistakenly given the AstraZeneca jab despite no COVID-19 vaccine being approved for children in Australia.
The Therapeutic Goods Administration (TGA) has confirmed it has received and processed 13 reports of the AstraZeneca vaccine being administered to adolescents "aged between 15 and 17" years.
The Therapeutic Goods Administration (TGA) has confirmed the death of a 48-year-old NSW woman was "likely" linked to the AstraZeneca COVID vaccine.
Genene Norris died four days after receiving the vaccine on April 8, after having developed rare blood clots.
After meeting last night, the TGA Vaccine Safety Investigation Group released its report where it declared that a "causative link" to the vaccination "should be assumed at this time".
CHILDREN GIVEN JAB IN ERROR
Teens as young as 14 have been mistakenly given the AstraZeneca jab despite no COVID-19 vaccine being approved for children in Australia.
The Therapeutic Goods Administration (TGA) has confirmed it has received and processed 13 reports of the AstraZeneca vaccine being administered to adolescents "aged between 15 and 17" years.
India Case Surge; Tokyo's Olympics Concern: Virus Update
Article content
(Bloomberg) — India reported more than 200,000 new infections on Thursday — its highest one-day surge since the pandemic broke out. A senior official in Japan’s ruling party indicated that canceling the Tokyo Olympics was an option, according to a media report, as cases in the city rose to the highest in more than two months.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
We apologize, but this video has failed to load.
Article content
(Bloomberg) — India reported more than 200,000 new infections on Thursday — its highest one-day surge since the pandemic broke out. A senior official in Japan’s ruling party indicated that canceling the Tokyo Olympics was an option, according to a media report, as cases in the city rose to the highest in more than two months.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
We apologize, but this video has failed to load.
Coronavirus digest: J&J vaccine maker rejects blood clot claims | News | DW
COVID-19 Special: Tough choices – choosing the right vaccine
J&J scientists wrote in a letter in the
New England Journal of Medicine that "evidence is insufficient to establish a causal relationship between these events" and this type of vaccine.
They argued that while both jabs followed the same technology, they coded different types of protein to the cells, concluding that "the two adenoviral vector COVID-19 vaccines may have quite different biologic effects."
Their letter came in response to an earlier report published by the University of Nebraska, which stated that the rare blood clots "could be related to adenoviral vector vaccines."
COVID-19 Special: Tough choices – choosing the right vaccine
J&J scientists wrote in a letter in the
New England Journal of Medicine that "evidence is insufficient to establish a causal relationship between these events" and this type of vaccine.
They argued that while both jabs followed the same technology, they coded different types of protein to the cells, concluding that "the two adenoviral vector COVID-19 vaccines may have quite different biologic effects."
Their letter came in response to an earlier report published by the University of Nebraska, which stated that the rare blood clots "could be related to adenoviral vector vaccines."
Australia PM Cautions Against 'Making Conclusions' After Woman Dies Following COVID-19 Vaccination
Australia PM Cautions Against ‘Making Conclusions’ After Woman Dies Following COVID-19 Vaccination
Prime Minister Scott Morrison and Premier Gladys Berejiklian have urged the public not to jump to any conclusions after a woman died after developing blood clots following her COVID-19 jab.
The 48-year-old woman from New South Wales (NSW) received her AstraZeneca vaccine last Friday and developed blood clots soon after.
Therapeutic Goods Administration (TGA) and NSW Health are currently investigating whether the death was linked to the vaccine.
“It has not yet been established whether there is any link between the COVID-19 vaccine and the tragic death reported by NSW health officials,” TGA said in a statement. “NSW Health has said there is no confirmed link, but further investigations are underway.”
Australia PM Cautions Against ‘Making Conclusions’ After Woman Dies Following COVID-19 Vaccination
Prime Minister Scott Morrison and Premier Gladys Berejiklian have urged the public not to jump to any conclusions after a woman died after developing blood clots following her COVID-19 jab.
The 48-year-old woman from New South Wales (NSW) received her AstraZeneca vaccine last Friday and developed blood clots soon after.
Therapeutic Goods Administration (TGA) and NSW Health are currently investigating whether the death was linked to the vaccine.
“It has not yet been established whether there is any link between the COVID-19 vaccine and the tragic death reported by NSW health officials,” TGA said in a statement. “NSW Health has said there is no confirmed link, but further investigations are underway.”
Aussie woman dead after taking COVID vaccination
Health
by Ellen Ransley , James Hall , Jade Gailberger , Sue Dunlevy and Tiffany Bakker
15th Apr 2021 6:37 PM
A woman that took a COVID vaccination and developed blood clots hours after has died in NSW.
The woman, a 48-year-old from the Central Coast, was given the vaccine last Friday but developed blood clots the next day and was put on dialysis, the Daily Mail reports.
She was a diabetic and was in an intensive care unit when she died yesterday, according to the media outlet.
A NSW Health spokesman said the department could not confirm any link between the vaccine and the woman's death.
Health
by Ellen Ransley , James Hall , Jade Gailberger , Sue Dunlevy and Tiffany Bakker
15th Apr 2021 6:37 PM
A woman that took a COVID vaccination and developed blood clots hours after has died in NSW.
The woman, a 48-year-old from the Central Coast, was given the vaccine last Friday but developed blood clots the next day and was put on dialysis, the Daily Mail reports.
She was a diabetic and was in an intensive care unit when she died yesterday, according to the media outlet.
A NSW Health spokesman said the department could not confirm any link between the vaccine and the woman's death.
The Vaccine-Related Blood Clot Mystery Must Be Solved
DeAgostini / Getty / Katie Martin / The Atlantic
For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.
DeAgostini / Getty / Katie Martin / The Atlantic
For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.
Woman's death 'likely linked to vaccination'
Womanâs death âlikely linked to vaccinationâ
The Therapeutic Goods Administration has ruled the death of an Australian woman after taking the AstraZeneca jab is âlikely to be linked to vaccinationâ.
Health
by Maria Bervanakis
Premium Content
Subscriber only
Australia's medical regulator has ruled that the death of a NSW woman following blood clots within days of taking the AstraZeneca COVID-19 jab is "likely to be linked to vaccination".
The 48-year-old woman from the Central Coast received the vaccine on the morning of April 8, prior to the decision by the Australian Technical Advisory Group Immunisation (AAGI) and the announcement by Government that the Pfizer vaccine was preferred for patients aged under 50.
Womanâs death âlikely linked to vaccinationâ
The Therapeutic Goods Administration has ruled the death of an Australian woman after taking the AstraZeneca jab is âlikely to be linked to vaccinationâ.
Health
by Maria Bervanakis
Premium Content
Subscriber only
Australia's medical regulator has ruled that the death of a NSW woman following blood clots within days of taking the AstraZeneca COVID-19 jab is "likely to be linked to vaccination".
The 48-year-old woman from the Central Coast received the vaccine on the morning of April 8, prior to the decision by the Australian Technical Advisory Group Immunisation (AAGI) and the announcement by Government that the Pfizer vaccine was preferred for patients aged under 50.
Woman's death 'likely linked to vaccination' | Ballina Shire Advocate
Womanâs death âlikely linked to vaccinationâ
The Therapeutic Goods Administration has ruled the death of an Australian woman after taking the AstraZeneca jab is âlikely to be linked to vaccinationâ.
Health
by Maria Bervanakis
Premium Content
Subscriber only
Australia's medical regulator has ruled that the death of a NSW woman following blood clots within days of taking the AstraZeneca COVID-19 jab is "likely to be linked to vaccination".
The 48-year-old woman from the Central Coast received the vaccine on the morning of April 8, prior to the decision by the Australian Technical Advisory Group Immunisation (AAGI) and the announcement by Government that the Pfizer vaccine was preferred for patients aged under 50.
Womanâs death âlikely linked to vaccinationâ
The Therapeutic Goods Administration has ruled the death of an Australian woman after taking the AstraZeneca jab is âlikely to be linked to vaccinationâ.
Health
by Maria Bervanakis
Premium Content
Subscriber only
Australia's medical regulator has ruled that the death of a NSW woman following blood clots within days of taking the AstraZeneca COVID-19 jab is "likely to be linked to vaccination".
The 48-year-old woman from the Central Coast received the vaccine on the morning of April 8, prior to the decision by the Australian Technical Advisory Group Immunisation (AAGI) and the announcement by Government that the Pfizer vaccine was preferred for patients aged under 50.
14 April 2021 Coronavirus Charts and News: People Who Get Their COVID Information From Social Media Are More Hesitant About Getting Vaccinated. Much More On Vaccine Caused Blood Clots.
A week after receiving the AstraZeneca COVID-19 vaccine, a 37-year-old woman in Norway went to the emergency department with fever and persistent headaches. A CAT scan of her head showed a blood clot in blood vessels involved in draining the brain, but her levels of platelets, involved in clotting, were low. She was treated with platelet infusions and a blood thinner, but had a bleed in her brain the next day. She underwent surgery to relieve the pressure on her brain but died two days later.
This is the side effect, known as cerebral venous sinus thrombosis, that has caused a week of worries around the COVID-19 vaccine developed by AstraZeneca. On Tuesday, the U.S. government said that it had seen the same effect six times among the 6.8 million people given a dose of a similar vaccine, from Johnson & Johnson, and that it recommended a pause on use of that vaccine "out of an abundance of caution," while researchers investigated.
A week after receiving the AstraZeneca COVID-19 vaccine, a 37-year-old woman in Norway went to the emergency department with fever and persistent headaches. A CAT scan of her head showed a blood clot in blood vessels involved in draining the brain, but her levels of platelets, involved in clotting, were low. She was treated with platelet infusions and a blood thinner, but had a bleed in her brain the next day. She underwent surgery to relieve the pressure on her brain but died two days later.
This is the side effect, known as cerebral venous sinus thrombosis, that has caused a week of worries around the COVID-19 vaccine developed by AstraZeneca. On Tuesday, the U.S. government said that it had seen the same effect six times among the 6.8 million people given a dose of a similar vaccine, from Johnson & Johnson, and that it recommended a pause on use of that vaccine "out of an abundance of caution," while researchers investigated.
Bow Valley vaccine capacity improves from late March
Article content
A strain on coronavirus vaccine supply that appeared to disproportionately affect Bow Valley pharmacies has been somewhat alleviated, although shortages continue.
“There was a shortage in vaccines which occurred a couple weeks ago, and the shortage was primarily due to a delayed shipment of the vaccine that was intended for pharmacies only,” said Banff-Kananaskis MLA Miranda Rosin in an April 10 phone call.
We apologize, but this video has failed to load.
Try refreshing your browser.
Bow Valley vaccine capacity improves from late March Back to video
“The AHS clinics had enough supply across southern Alberta and most of Alberta to continue inoculating but 170 pharmacies across the province did not, and they did not get their shipment, and that included all of the pharmacies in Canmore and Banff unfortunately.”
Article content
A strain on coronavirus vaccine supply that appeared to disproportionately affect Bow Valley pharmacies has been somewhat alleviated, although shortages continue.
“There was a shortage in vaccines which occurred a couple weeks ago, and the shortage was primarily due to a delayed shipment of the vaccine that was intended for pharmacies only,” said Banff-Kananaskis MLA Miranda Rosin in an April 10 phone call.
We apologize, but this video has failed to load.
Try refreshing your browser.
Bow Valley vaccine capacity improves from late March Back to video
“The AHS clinics had enough supply across southern Alberta and most of Alberta to continue inoculating but 170 pharmacies across the province did not, and they did not get their shipment, and that included all of the pharmacies in Canmore and Banff unfortunately.”
CDC's J&J Talk Ends Without Vote; India Case Surge: Virus Update
India Case Surge; Tokyo’s Olympics Concern: Virus Update
Bloomberg
1 hr ago
Bloomberg News
(Bloomberg) -- India reported more than 200,000 new infections on Thursday -- its highest one-day surge since the pandemic broke out. A senior official in Japan’s ruling party indicated that canceling the Tokyo Olympics was an option, according to a media report, as cases in the city rose to the highest in more than two months.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
India Case Surge; Tokyo’s Olympics Concern: Virus Update
Bloomberg
1 hr ago
Bloomberg News
(Bloomberg) -- India reported more than 200,000 new infections on Thursday -- its highest one-day surge since the pandemic broke out. A senior official in Japan’s ruling party indicated that canceling the Tokyo Olympics was an option, according to a media report, as cases in the city rose to the highest in more than two months.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
India Case Surge; Tokyo's Olympics Concern: Virus Update
Greece Lifts Curbs; India Daily Cases Top 200,000: Virus Update
Bloomberg
13 mins ago
Bloomberg News
(Bloomberg) -- India reported more than 200,000 new infections on Thursday -- its highest one-day surge since the pandemic broke out. A senior official in Japan’s ruling party indicated that canceling the Tokyo Olympics was an option as cases in the city rose to the highest in more than two months.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
Greece Lifts Curbs; India Daily Cases Top 200,000: Virus Update
Bloomberg
13 mins ago
Bloomberg News
(Bloomberg) -- India reported more than 200,000 new infections on Thursday -- its highest one-day surge since the pandemic broke out. A senior official in Japan’s ruling party indicated that canceling the Tokyo Olympics was an option as cases in the city rose to the highest in more than two months.
A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
Aussie woman dead after taking COVID vaccination
Health
by Ellen Ransley , James Hall , Jade Gailberger , Sue Dunlevy and Tiffany Bakker
15th Apr 2021 6:37 PM
A woman that took a COVID vaccination and developed blood clots hours after has died in NSW.
The woman, a 48-year-old from the Central Coast, was given the vaccine last Friday but developed blood clots the next day and was put on dialysis, the Daily Mail reports.
She was a diabetic and was in an intensive care unit when she died yesterday, according to the media outlet.
A NSW Health spokesman said the department could not confirm any link between the vaccine and the woman's death.
Health
by Ellen Ransley , James Hall , Jade Gailberger , Sue Dunlevy and Tiffany Bakker
15th Apr 2021 6:37 PM
A woman that took a COVID vaccination and developed blood clots hours after has died in NSW.
The woman, a 48-year-old from the Central Coast, was given the vaccine last Friday but developed blood clots the next day and was put on dialysis, the Daily Mail reports.
She was a diabetic and was in an intensive care unit when she died yesterday, according to the media outlet.
A NSW Health spokesman said the department could not confirm any link between the vaccine and the woman's death.
Health Alert: U.S. Embassy Monrovia (April 15, 2021) | U.S. Embassy in Liberia
Location: Monrovia, Liberia
Event: The Ministry of Health reports COVID-19 vaccines are available at the following locations: SOS Medical Clinic, St. Joseph Catholic Hospital, ELWA Hospital, JFK Hospital, Redemption Hospital, JDJ Hospital, 14 Military Hospital, and a mobile unit. Monitor local news and the Ministry of Health website for updates and information on the mobile unit location, or contact the clinic or hospital directly for more details.
The AstraZeneca first dose will be provided to people who are over 18 years of age. Enough vaccines will be reserved to ensure those who receive their first dose are able to get a second dose eight weeks after the first dose.
Location: Monrovia, Liberia
Event: The Ministry of Health reports COVID-19 vaccines are available at the following locations: SOS Medical Clinic, St. Joseph Catholic Hospital, ELWA Hospital, JFK Hospital, Redemption Hospital, JDJ Hospital, 14 Military Hospital, and a mobile unit. Monitor local news and the Ministry of Health website for updates and information on the mobile unit location, or contact the clinic or hospital directly for more details.
The AstraZeneca first dose will be provided to people who are over 18 years of age. Enough vaccines will be reserved to ensure those who receive their first dose are able to get a second dose eight weeks after the first dose.
COVID-19 vaccine-linked blood clots hinder rollout as Quebec case reported
/cloudfront-us-east-1.images.arcpublishing.com/tgam/74SF4WV2KZNYTI7CKCHJ5R2QWM.jpg)
Rick West/The Associated Press
Extremely rare cases of blood clots are hampering the rollout of two COVID-19 vaccines that Canada has purchased, as the country recorded its first case of the side effect from the AstraZeneca injection and the U.S. suspended use of the Johnson & Johnson version.
On Tuesday, the United States temporarily stopped its use of the Johnson & Johnson vaccine while it investigates reports of a rare and severe type of blood clot in individuals who received the single-dose shot. Similar blood clots have also been reported after the use of the Oxford-AstraZeneca vaccine. Both shots use the same vaccine technology, called adenovirus vector.
Rick West/The Associated Press
Extremely rare cases of blood clots are hampering the rollout of two COVID-19 vaccines that Canada has purchased, as the country recorded its first case of the side effect from the AstraZeneca injection and the U.S. suspended use of the Johnson & Johnson version.
On Tuesday, the United States temporarily stopped its use of the Johnson & Johnson vaccine while it investigates reports of a rare and severe type of blood clot in individuals who received the single-dose shot. Similar blood clots have also been reported after the use of the Oxford-AstraZeneca vaccine. Both shots use the same vaccine technology, called adenovirus vector.
Covid vaccines and rare blood clots are making headlines. Before you worry, here's everything you need to know
ET Panache NEWS
Powered by
Covid vaccines and rare blood clots are making headlines. Before you worry, here's everything you need to know
SECTIONS
Covid vaccines and rare blood clots are making headlines. Before you worry, here's everything you need to knowAP
Last Updated: Apr 14, 2021, 05:19 PM IST
Share
iStock
These are not typical blood clots. They're weird in two ways. First, they're occurring in unusual parts of the body, such as veins that drain blood from the brain. Second, those patients also have abnormally low levels of platelets - cells that help form clots - a condition normally linked to bleeding, not clotting.
ET Panache NEWS
Powered by
Covid vaccines and rare blood clots are making headlines. Before you worry, here's everything you need to know
SECTIONS
Covid vaccines and rare blood clots are making headlines. Before you worry, here's everything you need to knowAP
Last Updated: Apr 14, 2021, 05:19 PM IST
Share
iStock
These are not typical blood clots. They're weird in two ways. First, they're occurring in unusual parts of the body, such as veins that drain blood from the brain. Second, those patients also have abnormally low levels of platelets - cells that help form clots - a condition normally linked to bleeding, not clotting.
astrazeneca vaccine: Denmark drops AstraZeneca vaccine for good, in European first
Synopsis
Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.
Agencies
Denmark had continued to hold off using the vaccine as it conducted investigations of its own.
Denmark announced Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.
Synopsis
Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.
Agencies
Denmark had continued to hold off using the vaccine as it conducted investigations of its own.
Denmark announced Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.
10,000 ASTRAZENECA VACCINE EXPIRES
About 10,000 doses of the AstraZeneca Vaccine that the country received from the African Union (AU) on 26 March, 2021has been confirmed expired.
Confirming the development, Principal Secretary in the ministry of health, Dr. Charles Mwansambo was quick to disclose that the expiry is due to the short span that the doses had.
âWe received 102, 000 doses from the African Union on 26
th March. Unfortunately, these had a short expiry period. They are expiring on the 13
th of April and I am glad to report that most of these have been used.
âAs of Monday, we still had about 20, 000 doses remaining; so, I am hoping that once we get the statistics at the end of Tuesday, we should be around 10, 000 doses,â said Dr. Mwamsambo.
About 10,000 doses of the AstraZeneca Vaccine that the country received from the African Union (AU) on 26 March, 2021has been confirmed expired.
Confirming the development, Principal Secretary in the ministry of health, Dr. Charles Mwansambo was quick to disclose that the expiry is due to the short span that the doses had.
âWe received 102, 000 doses from the African Union on 26
th March. Unfortunately, these had a short expiry period. They are expiring on the 13
th of April and I am glad to report that most of these have been used.
âAs of Monday, we still had about 20, 000 doses remaining; so, I am hoping that once we get the statistics at the end of Tuesday, we should be around 10, 000 doses,â said Dr. Mwamsambo.
Covid-19 news archive: March and April 2021
This is an archive of the
Health
13 April 2021
Nurse Anna Briggs puts down a vial of the Johnson & Johnson COVID-19 vaccine at the Center for Empowering Refugees in collaboration with Native American.
Gabrielle Lurie/The San Francisco Chronicle via Getty Images
Latest coronavirus news as of 5pm on 13 April
There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine
US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April, the FDA and CDC said in a joint statement. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” the statement said.
This is an archive of the
Health
13 April 2021
Nurse Anna Briggs puts down a vial of the Johnson & Johnson COVID-19 vaccine at the Center for Empowering Refugees in collaboration with Native American.
Gabrielle Lurie/The San Francisco Chronicle via Getty Images
Latest coronavirus news as of 5pm on 13 April
There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine
US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April, the FDA and CDC said in a joint statement. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” the statement said.